Latest News about Initiation
Recent news which mentions Initiation
Concentra's Post-IPO Trading Levels Based On 'Its Dominant Market Position,' Says Analyst
August 20, 2024
From Benzinga
MediaAlpha Positioned for Strong Growth in Expanding Insurance Digital Advertising Market, Says Goldman Sachs
August 20, 2024
From Benzinga
ARS Pharmaceuticals 'Neffy Uniquely Positioned With Potential To Change Allergy Treatment Paradigm For First Time In 40 years:' Analyst
August 20, 2024
From Benzinga
OneStream's AI Integration, Expanding CFO Platform, and High Retention Rate Poised to Fuel Strong Market Growth, Analysts Say
August 19, 2024
From Benzinga
Lineage Set For Strong Growth Post-2024 With Tech Investments And Strategic Acquisitions: Analyst
August 19, 2024
From Benzinga
Concentra's High-Quality Business Model Attracts Analyst Attention, Initiates With Buy Rating
August 19, 2024
From Benzinga
From Benzinga
Oral Vaccine Focused Penny Stock Vaxart Is 'Uniquely Positioned', Analyst Sees Almost 83% Upside
August 15, 2024
From Benzinga
Gene Editing Korro Bio's Preclinical Data 'Best-In-Class', Analyst Initiates With Outperform Rating
August 14, 2024
From Benzinga
Artiva Biotherapeutics' Investigational Scalable Cell Therapies For Autoimmune Disorders, Analyst Initiate With Bullish Pitch
August 13, 2024
From Benzinga
Packaged Food Sector To See Mixed Performance Amid Economic Headwinds: Goldman Sachs
August 12, 2024
From Benzinga
New Hospital Operator On The Block Ardent Health Garners Interest As Analysts Initiate With Bullish View
August 12, 2024
From Benzinga
Rare Disease-Focused Applied Therapeutics' Lead Candidate Govorestat Has Blockbuster Potential, Analyst Sees 140% Stock Upside
July 31, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.